Use of traditional glucagon kits is low, as reported in previous studies [10–12], and the new finding is that the use is low in the totality of countries examined, so that a significant correlation was found between persons with diabetes or type 1 diabetes and units of glucagon sold each year. This evidence concerns the gene GCG and type 1 diabetes mellitus.